Track the Pharmanutra PHN stock price and the full directors' dealings record of the company, a listed equity based in Italy. Shares are quoted on the IT market, under the oversight of Consob. Operating in the Health Care sector, Pharmanutra PHN has published 12 public disclosures. Market capitalisation: €784.2m. The latest transaction was disclosed on 8 September 2025 (Other). The full history is free.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,502 of 29,064 companies
61.9
score / 100
Value
39
Quality
85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.